Viewing Study NCT02429466


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-02-08 @ 12:06 PM
Study NCT ID: NCT02429466
Status: COMPLETED
Last Update Posted: 2020-09-23
First Post: 2015-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Sponsor: Nasser Hanna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module